OB/GYN Update 2022 - Exhibitor: Evofem Biosciences

Obstetrics and Gynecology Update:
What Does The Evidence Tell Us?

Course# MOB23001, Oct 12 - 14, 2022
Marines’ Memorial Club & Hotel San Francisco, CA

evofem Logo

Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex.

To find out more visit www.evofem.com and www.phexxi.com  

Phexxi® is a registered trademark of Evofem Biosciences, Inc.


For more information, please contact:

Jaspreet Bakshi
[email protected]
(949) 973-5215

Robin Geyer
[email protected]
(209) 761-0010

Return to Virtual Exhibit Hall